Membrane Glycoproteins
- Name
- Membrane Glycoproteins
- Accession Number
- DBCAT002880
- Description
Glycoproteins found on the membrane or surface of cells.
- Drugs
Drug Drug Description Adecatumumab Investigated for use/treatment in breast cancer and prostate cancer. Thrombomodulin Alfa Investigated for use/treatment in blood preservative, blood (blood forming organ disorders, unspecified), sepsis and septicemia, and thrombosis. Recombinant CD40-ligand Recombinant CD40-ligand is under investigation in clinical trial NCT00053391 (Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma). Fibronectin Fibronectin is under investigation in clinical trial NCT01812239 (Vaginal Progesterone in Twins With Short Cervix). Cystic fibrosis transmembrane conductance regulator Cystic fibrosis transmembrane conductance regulator is under investigation in clinical trial NCT00004806 (Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis). Alefacept A recombinant fusion protein that binds CD2 and is used treat moderate to severe plaque psoriasis. PRO-542 Investigated for use/treatment in acquired immune deficiency syndrome (AIDS) and aids-related infections, HIV infection, and pediatric indications. Pegdinetanib Investigated for use/treatment in cancer/tumors (unspecified) and macular degeneration. GI-6207 Not Annotated EDI-200 EDI-200 is a fusion protein consisting of human immunoglobim G1 constant region Fc region fused to the human receptor binding domain of ectodysplasin-A1. - Drugs & Drug Targets